Skip to content

Welcome to Discover Pharma! Today is : November 10, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Research & Development

  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    iOnctura reports immune response with roginolisib in resistant lung cancer

    iOnctura has reported immune-cell changes with roginolisib combinations in patients [...]

    November 10, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    PsiThera raises $25M to advance oral TNFα and TL1A drugs

    PsiThera has raised $25 million to advance oral TNFα and [...]

    November 10, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Mineralys reports sustained blood pressure reduction with lorundrostat at week 48

    Mineralys Therapeutics has reported sustained blood pressure reductions with investigational [...]

    November 9, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Research & Development,Therapeutic Areas

    PhaSER Biomedical secures $2.7m Gates Foundation grant renewal

    Scottish biotech PhaSER Biomedical has secured a two-year Gates Foundation [...]

    November 9, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Research & Development

    AbbVie expands Oxford R&D with new research facility

    AbbVie has opened a new 12,000-square-foot Oxford research facility to [...]

    November 6, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Research & Development

    ALLOX raises $10.5M to advance AI drug discovery platform

    ALLOX has raised $10.5 million in seed financing to expand [...]

    November 2, 2026
  • Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Nobel Prize in Chemistry 2026 recognises discoveries in asymmetric synthesis

    Henri B Kagan and Kenso Soai have been awarded the [...]

    November 2, 2026
  • Digital & Data,Research & Development

    Wiley launches online platform for spectral data and compound identification

    Wiley has launched a browser-based analytical research platform combining spectral [...]

    November 2, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    ALLOX raises €9.4m for allosteric drug discovery

    ALLOX has raised €9.4 million in seed financing to expand [...]

    October 29, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Newron completes Phase 3 trial enrolment in schizophrenia

    Newron Pharmaceuticals has completed enrolment of 618 patients in its [...]

    October 29, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Wiley launches online platform for spectral data and compound identification
    Categories: Digital & Data, Research & Development
  • iOnctura to present roginolisib data in immunotherapy-resistant lung cancer
    Categories: Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • Lonza expands bioconjugation manufacturing capacity for ADCs
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top